
Opinion|Videos|January 28, 2025
Streamlining Transitions Between Academic and Community Centers
Author(s)Jeffrey V. Matous, MD
Jeffrey V. Matous, MD, discusses how telehealth and remote monitoring can enhance the safe administration of bispecific antibody therapies in community settings, especially for rural or underserved populations, while emphasizing the importance of communication and collaboration between academic and community practices to improve delivery and coordination of care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can telehealth and remote monitoring, including tools for managing CRS or other toxicities, support the safe administration of bispecific antibody therapies in community settings while expanding access for rural or underserved populations?
- How can academic and community practices strengthen communication and collaboration to support the delivery of bispecific antibody therapies, and what tools or frameworks might facilitate this coordination?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
5 Things to Know as Flu Season Begins
3
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
4
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
5










































